Literature DB >> 15202019

Upregulation of tumour endothelial marker-8 by interleukin-1beta and its impact in IL-1beta induced angiogenesis.

Khaled A Rmali1, Mahir A A Al-Rawi, Christian Parr, Malcolm C A Puntis, Wen G Jiang.   

Abstract

Tumour endothelial marker-8 (TEM-8) has been found to be selectively upregulated in tumour-associated endothelial cells and is implicated in tumour specific angiogenesis. Specific factors, indigenous to tissues and tumours that regulate the TEM-8 mechanism in angiogenesis are not defined. We report for the first time that interleukin-1beta induces the expression of TEM-8 in endothelial cells. Human vascular endothelial cells (HECV), which strongly express IL-1beta receptor (as revealed by RT-PCR, Western blotting), increased the level of TEM-8 expression following stimulation with IL-1beta (as revealed by conventional and quantitative RT-PCR). Using a newly developed antibody to human TEM-8, we have further demonstrated that IL-1beta significantly raised the level of TEM-8 at the protein level, as revealed by Western blotting. In vitro tubule forming assay, revealed that IL-1beta significantly induced the formation of capillary-like tubules from the HECV cells, accompanied by an increase in TEM-8 expression. It is concluded that IL-1beta is a powerful regulator of the expression of TEM-8 in vascular endothelial cells. Our results suggest an important pathway through which IL-1beta regulates tumour-associated angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15202019

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  13 in total

1.  Imaging tumor endothelial marker 8 using an 18F-labeled peptide.

Authors:  Qimeng Quan; Min Yang; Haokao Gao; Lei Zhu; Xin Lin; Ning Guo; Guixiang Zhang; Henry S Eden; Gang Niu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-04       Impact factor: 9.236

Review 2.  Breaking the wall: targeting of the endothelium by pathogenic bacteria.

Authors:  Emmanuel Lemichez; Marc Lecuit; Xavier Nassif; Sandrine Bourdoulous
Journal:  Nat Rev Microbiol       Date:  2009-12-30       Impact factor: 60.633

3.  Prognostic values of tumor endothelial markers in patients with colorectal cancer.

Authors:  K A Rmali; M C A Puntis; W G Jiang
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

4.  The role of NF-kappaB and H3K27me3 demethylase, Jmjd3, on the anthrax lethal toxin tolerance of RAW 264.7 cells.

Authors:  Nando Dulal Das; Kyoung Hwa Jung; Young Gyu Chai
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

5.  Prognostic value of tumour endothelial markers in patients with endometrial cancer.

Authors:  Nick A Bersinger; Brigitte Schneider; Stephan A Vorburger; Silke Johann; Daniel Candinas; Michael D Mueller
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

6.  Toxicity of anthrax toxin is influenced by receptor expression.

Authors:  Sarah C Taft; Alison A Weiss
Journal:  Clin Vaccine Immunol       Date:  2008-07-02

7.  Cathepsin B-mediated autophagy flux facilitates the anthrax toxin receptor 2-mediated delivery of anthrax lethal factor into the cytoplasm.

Authors:  Soon-Duck Ha; Boram Ham; Jeremy Mogridge; Paul Saftig; Shengcai Lin; Sung Ouk Kim
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

Review 8.  Receptors of anthrax toxin and cell entry.

Authors:  Gisou van der Goot; John A T Young
Journal:  Mol Aspects Med       Date:  2009-09-02

9.  Injection of Staphylococcus aureus EDIN by the Bacillus anthracis protective antigen machinery induces vascular permeability.

Authors:  Monica Rolando; Patrick Munro; Caroline Stefani; Patrick Auberger; Gilles Flatau; Emmanuel Lemichez
Journal:  Infect Immun       Date:  2009-06-22       Impact factor: 3.441

10.  Broad expression analysis of human ANTXR1/TEM8 transcripts reveals differential expression and novel splizce variants.

Authors:  Micaela Vargas; Raghavendra Karamsetty; Stephen H Leppla; G Jilani Chaudry
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.